Mount Yale Investment Advisors LLC Has $1.91 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Mount Yale Investment Advisors LLC cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 3.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,690 shares of the financial services provider’s stock after selling 341 shares during the period. Mount Yale Investment Advisors LLC’s holdings in CME Group were worth $1,905,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of CME Group by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock worth $7,044,821,000 after purchasing an additional 215,044 shares in the last quarter. Capital International Investors grew its stake in CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after acquiring an additional 3,069,806 shares during the period. Capital World Investors increased its holdings in shares of CME Group by 8.7% in the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after acquiring an additional 1,172,575 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of CME Group by 2.9% during the first quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock worth $1,462,678,000 after purchasing an additional 189,842 shares during the period. Finally, Parnassus Investments LLC raised its position in shares of CME Group by 0.4% during the fourth quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock worth $1,193,551,000 after purchasing an additional 23,583 shares during the period. Institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on CME. Deutsche Bank Aktiengesellschaft increased their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. Piper Sandler restated an “overweight” rating and set a $225.00 price objective on shares of CME Group in a report on Tuesday, August 20th. Barclays boosted their price objective on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $212.00 to $177.00 in a report on Tuesday, September 3rd. Finally, Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $209.73.

CME Group Stock Performance

CME opened at $213.16 on Monday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The business’s 50-day simple moving average is $207.86 and its 200 day simple moving average is $207.36. The firm has a market capitalization of $76.75 billion, a PE ratio of 24.25, a PEG ratio of 8.85 and a beta of 0.55. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $223.80.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.30 EPS. As a group, sell-side analysts expect that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.16%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.